Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regpara in chronic dialysis patients with secondary hyperparathyroidism
NCT02056730Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Nov 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Chulalongkorn University. Started Nov 2013; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02056730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056730.